Rosuco 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium
Prescription medication
Korea Novartis Co., Ltd.
MFDS item code 201404475 · Approved 2014.09.30
This product's status changed to Approval withdrawn on 2023.06.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is primarily used as an adjunct therapy for patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone are not sufficient. It is also used in combination with other therapies for patients with homozygous familial hypercholesterolemia. It helps lower total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby slowing the progression of atherosclerosis. It can also be used as an adjunct to dietary therapy in children with certain familial hypercholesterolemia and is applicable for patients with primary dysbetalipoproteinemia. Furthermore, it may provide risk reduction for stroke, myocardial infarction, and artery revascularization in middle-aged patients at high risk for cardiovascular diseases. In summary, this medication is effectively used for reducing the risk of various dyslipidemias and cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and should continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: Dose adjustment is not necessary. 4. Patients with renal impairment: Dose adjustment is not necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
Age 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy in children under 10 years of age have not been established.
This medication should not be administered to certain patients. First, individuals with an allergy to the components of this medication should not use it. Additionally, patients with severely impaired liver function or unexplained elevated liver enzyme levels should not take this medication. Those with muscle problems or myopathy should also avoid this medication. Co-administration with the immunosuppressant cyclosporine is contraindicated. Patients with significantly impaired kidney function should not take this medication. Pregnant or breastfeeding women and fertile women not using appropriate contraception should also refrain from using this medication. Particularly, in high doses (40 mg), this medication should not be administered to patients at high risk for muscle complications. This medication contains lactose, so individuals with lactose intolerance should avoid it. Regular monitoring of liver function or muscle condition is required during use, and patients with a history of heavy alcohol consumption or liver disease should take extra caution. If symptoms such as muscle pain, weakness, or cramps occur, medical personnel should be notified immediately, and if accompanied by elevated muscle enzyme levels, the medication should be discontinued. Muscle enzyme levels may increase after exercise or due to other causes, so testing should be performed at an appropriate time. This medication may interact with other drugs, so any concomitant medications should be reported to healthcare providers. Particularly, concomitant use with some antiviral agents, immunosuppressants, certain antibiotics, and fibrate medications may increase the risk of muscle damage. The safety of this medication has not been established during pregnancy or lactation, and women of childbearing potential must use appropriate contraception. In cases of overdose, since there is no specific antidote, treatment should be symptomatic with monitoring of liver function and muscle enzyme levels. This medication can rarely cause severe skin reactions or liver damage, so if symptoms such as skin rash or jaundice occur, it should be discontinued immediately, and healthcare providers should be consulted. Caution is required in daily life as dizziness may occur, especially when driving or operating machinery.
Angioedema, allergic reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius in order to preserve its efficacy and safety for a long time.
Brown, round, film-coated tablet
28 tablets (7 tablets/Alu-Alu x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium
Prescription medication
Korea Novartis Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.